Tyra Biosciences (TYRA) EPS (Weighted Average and Diluted) (2021 - 2026)
Quarterly EPS (Weighted Average and Diluted) fell 36.17% to -$0.64 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$2.17 through Mar 2026, down 33.13% year-over-year, with the annual reading at -$2.01 for FY2025, 33.11% down from the prior year.
Tyra Biosciences filings provide 6 years of EPS (Weighted Average and Diluted) readings, the most recent being -$0.64 for Q1 2026.
- EPS (Weighted Average and Diluted) hit -$0.64 in Q1 2026 for Tyra Biosciences, down from -$0.56 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at -$0.28 in Q1 2023 and bottomed at -$0.64 in Q1 2026.
- Average EPS (Weighted Average and Diluted) over 5 years is -$0.42, with a median of -$0.41 recorded in 2024.
- Peak annual rise in EPS (Weighted Average and Diluted) hit 85.19% in 2022, while the deepest fall reached 117.44% in 2022.
- Tyra Biosciences' EPS (Weighted Average and Diluted) stood at -$0.3 in 2022, then plummeted by 76.67% to -$0.53 in 2023, then rose by 18.87% to -$0.43 in 2024, then crashed by 30.23% to -$0.56 in 2025, then fell by 14.29% to -$0.64 in 2026.
- Per Business Quant, the three most recent readings for TYRA's EPS (Weighted Average and Diluted) are -$0.64 (Q1 2026), -$0.56 (Q4 2025), and -$0.5 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -4.43 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 3,086.42 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 4.02 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 6.75 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.51 |
| 10 | Tyra Biosciences | 2.03 Bn | 2.03 Bn | - | -0.64 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.64 |
| Dec 31, 2025 | -0.56 |
| Sep 30, 2025 | -0.50 |
| Jun 30, 2025 | -0.47 |
| Mar 31, 2025 | -0.47 |
| Dec 31, 2024 | -0.43 |
| Sep 30, 2024 | -0.41 |
| Jun 30, 2024 | -0.32 |
| Mar 31, 2024 | -0.35 |
| Dec 31, 2023 | -0.53 |
| Sep 30, 2023 | -0.49 |
| Jun 30, 2023 | -0.31 |
| Mar 31, 2023 | -0.28 |
| Dec 31, 2022 | -0.30 |
| Sep 30, 2022 | -0.30 |
| Jun 30, 2022 | -0.36 |
| Mar 31, 2022 | -0.36 |
| Dec 31, 2021 | 1.72 |
| Sep 30, 2021 | -0.72 |
| Jun 30, 2021 | -2.43 |